Search filters

List of works by Marc Poirot

5,6-Epoxy-cholesterols contribute to the anticancer pharmacology of tamoxifen in breast cancer cells

scientific article published on 7 March 2013

A fast UPLC-HILIC method for an accurate quantification of dendrogenin A in human tissues

scientific article published on 12 August 2019

Auraptene is an inhibitor of cholesterol esterification and a modulator of estrogen receptors.

scientific article published on 11 August 2010

Bryonolic Acid Blocks Cancer Cell Clonogenicity and Invasiveness through the Inhibition of Fatty Acid: Cholesteryl Ester Formation

scientific article published on 12 February 2018

Cancer. Cholesterol and cancer, in the balance

scientific article published on 01 March 2014

Characterization of a benzyl-phenoxy-ethanamine binding protein in Trypanosoma equiperdum and the possible relation between binding affinity and trypanocidal activity.

scientific article published on April 1993

Characterization of the membranous antiestrogen binding protein: I. Partial purification of the protein in its active state

scientific article published on 01 January 1994

Characterization of the membranous antiestrogen binding protein: II. Purification to homogeneity

scientific article published on 01 January 1994

Chemistry, biochemistry, metabolic fate and mechanism of action of 6-oxo-cholestan-3β,5α-diol (OCDO), a tumor promoter and cholesterol metabolite.

scientific article published on 11 April 2018

Cholesterol epoxide hydrolase and cancer ⬇️

scientific article published on August 21, 2012

Cholesterol metabolism and cancer: the good, the bad and the ugly ⬇️

scientific article published on October 26, 2012

Cholesterol metabolism and resistance to tamoxifen.

scientific article published on 11 October 2012

Cholesterol-5,6-epoxides: chemistry, biochemistry, metabolic fate and cancer.

scientific article published on 18 May 2012

Contrasting effects of prenyltransferase inhibitors on estrogen-dependent cell cycle progression and estrogen receptor-mediated transcriptional activity in MCF-7 cells.

scientific article published in March 2003

Cytosolic type II estrogen binding site in rat uterus: specific photolabeling with estrone

scientific article published on 01 January 1992

Dendrogenin A Enhances Anti-Leukemic Effect of Anthracycline in Acute Myeloid Leukemia

scientific article published on 12 October 2020

Dendrogenin A drives LXR to trigger lethal autophagy in cancers.

scientific article published on 4 December 2017

Development of a new radioligand for cholecystokinin receptor subtype 2 scintigraphy: from molecular modeling to in vivo evaluation.

scientific article published on 19 May 2010

Exosomes account for vesicle-mediated transcellular transport of activatable phospholipases and prostaglandins.

scientific article

Exosomes as intercellular signalosomes and pharmacological effectors.

scientific article published on March 2011

Exosomes as new vesicular lipid transporters involved in cell-cell communication and various pathophysiologies.

scientific article published on 16 October 2013

Extracellular vesicles: lipids as key components of their biogenesis and functions

scientific article published on 15 May 2018

Farnesyl-transferase inhibitor R115,777 enhances tamoxifen inhibition of MCF-7 cell growth through estrogen receptor dependent and independent pathways.

scientific article

Flavonoids differentially modulate liver X receptors activity-Structure-function relationship analysis

scientific article published on 05 April 2019

From tamoxifen to dendrogenin A: The discovery of a mammalian tumor suppressor and cholesterol metabolite.

scientific article published on June 2016

Further evidence for a biological role of anti-estrogen-binding sites in mediating the growth inhibitory action of diphenylmethane derivatives

scientific article published in January 1988

Guidelines for the use and interpretation of assays for monitoring autophagy

scientific article

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

scientific article

HPLC Analysis and Skin Whitening Effects of Umbelliprenin-containing Extracts of , , and

scientific article published on 30 January 2019

High tumorigenic potential of a constitutively active mutant of the cholecystokinin 2 receptor.

scientific article published on September 2003

Human monocyte recognition of adenosine-based cyclic dinucleotides unveils the A2a Gαs protein-coupled receptor tonic inhibition of mitochondrially induced cell death

scientific article published on 10 November 2014

Identification of a new stilbene-derived inducer of paraoxonase 1 and ligand of the Aryl hydrocarbon Receptor.

scientific article

Identification of a tumor-promoter cholesterol metabolite in human breast cancers acting through the glucocorticoid receptor

scientific article

Identification of tyrosine 189 and asparagine 358 of the cholecystokinin 2 receptor in direct interaction with the crucial C-terminal amide of cholecystokinin by molecular modeling, site-directed mutagenesis, and structure/affinity studies

scientific article (publication date: May 2003)

Importance of cholesterol and oxysterols metabolism in the pharmacology of tamoxifen and other AEBS ligands ⬇️

scientific article published on May 27, 2011

Improvement of 5,6α-epoxycholesterol, 5,6β-epoxycholesterol, cholestane-3β,5α,6β-triol and 6-oxo-cholestan-3β,5α-diol recovery for quantification by GC/MS.

scientific article published on 26 May 2017

Improving the efficacy of hormone therapy in breast cancer: The role of cholesterol metabolism in SERM-mediated autophagy, cell differentiation and death

scientific article

Insights into the cholecystokinin 2 receptor binding site and processes of activation

scientific article published on 22 September 2006

Insulin and estrogen receptor ligand influence the FGF-2 activities in MCF-7 breast cancer cells

scientific article published on February 2003

Ligand-dependent transcriptional induction of lethal autophagy: a new perspective for cancer treatment

scientific article published on 25 January 2018

Ligands of the antiestrogen-binding site induce active cell death and autophagy in human breast cancer cells through the modulation of cholesterol metabolism

scientific article

MAPK14/p38α confers irinotecan resistance to TP53-defective cells by inducing survival autophagy.

scientific article published on 31 May 2012

Microsomal antiestrogen-binding site ligands induce growth control and differentiation of human breast cancer cells through the modulation of cholesterol metabolism.

scientific article

Microsomal epoxide hydrolase of rat liver is a subunit of theanti-oestrogen-binding site ⬇️

scientific article published on August 15, 1998

Molecular characterization of the microsomal tamoxifen binding site

scientific article

Natural and semisynthetic oxyprenylated aromatic compounds as stimulators or inhibitors of melanogenesis

scientific article published on 14 March 2019

One step synthesis of 6-oxo-cholestan-3β,5α-diol.

scientific article published on 4 February 2014

Oxysterols and related sterols: implications in pharmacology and pathophysiology

scientific article published on 9 May 2013

Oxysterols: An expanding family of structurally diversified bioactive steroids

scientific article published on 31 July 2019

Progesterone and a phospholipase inhibitor increase the endosomal bis(monoacylglycero)phosphate content and block HIV viral particle intercellular transmission

scientific article published on 15 June 2013

Quantitative analysis of the tumor suppressor dendrogenin A using liquid chromatography tandem mass spectrometry.

scientific article

Signaling through cholesterol esterification: a new pathway for the cholecystokinin 2 receptor involved in cell growth and invasion

scientific article

Sterol metabolism and cancer

scientific article

Structural similitudes between cytotoxic antiestrogen-binding site (AEBS) ligands and cytotoxic sigma receptor ligands. Evidence for a relationship between cytotoxicity and affinity for AEBS or sigma-2 receptor but not for sigma-1 receptor

scientific article

Synthesis and biological properties of new stilbene derivatives of resveratrol as new selective aryl hydrocarbon modulators.

scientific article

Synthesis of new alkylaminooxysterols with potent cell differentiating activities: identification of leads for the treatment of cancer and neurodegenerative diseases.

scientific article published on December 2009

Synthesis, characterization and in vitro evaluation of new oxorhenium- and oxotechnetium-CCK4 derivatives as molecular imaging agents for CCK2-receptor targeting.

scientific article published on 8 October 2009

Tamoxifen is a potent inhibitor of cholesterol esterification and prevents the formation of foam cells.

scientific article published on 14 November 2003

Technical note: Hapten synthesis, antibody production and development of an enzyme-linked immunosorbent assay for detection of the natural steroidal alkaloid Dendrogenin A.

scientific article

The 5,6-epoxycholesterol metabolic pathway in breast cancer: emergence of new pharmacological targets

scientific article published on 21 July 2020

The Effects of Cholesterol-Derived Oncometabolites on Nuclear Receptor Function in Cancer

scientific article published on 17 August 2018

The anti-proliferative properties of 4-benzylphenoxy ethanamine derivatives are mediated by the anti-estrogen binding site (ABS), whereas the anti-estrogenic effects of trifluopromazine are not.

scientific article published in August 1990

The cholesterol-derived metabolite dendrogenin A functionally reprograms breast adenocarcinoma and undifferentiated thyroid cancer cells

scientific article published on 03 June 2019

The novel steroidal alkaloids dendrogenin A and B promote proliferation of adult neural stem cells

scientific article published on 06 January 2014

The prototypical inhibitor of cholesterol esterification, Sah 58-035 [3-[decyldimethylsilyl]-n-[2-(4-methylphenyl)-1-phenylethyl]propanamide], is an agonist of estrogen receptors.

scientific article published on 11 July 2006

The tumor-suppressor cholesterol metabolite, dendrogenin A, is a new class of LXR modulator activating lethal autophagy in cancers.

scientific article published on 31 January 2018

When cholesterol meets histamine, it gives rise to dendrogenin A: a tumour suppressor metabolite

scientific article published on April 2016

Paulina is supported by:

About Paulina

Help